Join an engaging webinar and dive into the evolving field of diagnostic technologies. Topics for discussion will include how these innovations are shaping healthcare, key factors to consider for a successful diagnostic strategy and effective methods to measure and maximize diagnostic investments. This session will also discuss how groundbreaking advancements are transforming cancer diagnostics and treatment decisions. By the end of the webinar, participants will be equipped to reimagine diagnostic capabilities as a strategic organizational asset, develop forward-thinking approaches to diagnostic technology integration and lead transformative change in healthcare delivery through precision diagnostics.

Learning Objectives:

• Understand the transformative impact of precision diagnostics
• Identify key strategic considerations when developing a comprehensive precision diagnostics framework
• Explore methods to measure and maximize diagnostic investment

Faculty:

Manmeet Ahluwalia, MD, FASCO, Chief of Medical Oncology/Scientific Officer/Deputy Director, Miami Cancer Institute

Thomas Slavin, MD, FACMGG, DABMD, Chief Clinical Officer of Molecular Oncology/Medical Director of Haystack Oncology, Quest Diagnostics

ACHE Qualifying Education Credit 

This activity is eligible for 1 ACHE Qualifying Education credit toward earning or maintaining your FACHE credential. 

Credits must be self-reported at My ACHE upon completion of this activity. 

Thank You, Quest

This program is made possible in part by the support of Quest Diagnostics, an ACHE Premier Corporate Partner. ACHE would like to thank Quest Diagnostics for its commitment to ACHE and helping us advance healthcare management excellence. Find more information about Quest Diagnostics here.